A1BTO

(3M,5P,6M)-5-(1H-1,2,3-benzotriazol-1-yl)-6-(3-chlorophenyl)-3-(isoquinolin-4-yl)-1-(prop-2-yn-1-yl)pyrimidine-2,4(1H,3H)-dione

Created:	2025-01-16
Last modified:	2025-07-23

Find Related PDB Entry
1 entries where A1BTO is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	54
Chiral Atom Count	0
Bond Count	59
Aromatic Bond Count	27

2D diagram of A1BTO

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(3M,5P,6M)-5-(1H-1,2,3-benzotriazol-1-yl)-6-(3-chlorophenyl)-3-(isoquinolin-4-yl)-1-(prop-2-yn-1-yl)pyrimidine-2,4(1H,3H)-dione
Systematic Name (OpenEye OEToolkits)	5-(benzotriazol-1-yl)-6-(3-chlorophenyl)-3-isoquinolin-4-yl-1-prop-2-ynyl-pyrimidine-2,4-dione
Formula	C₂₈ H₁₇ Cl N₆ O₂
Molecular Weight	504.927
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	Clc1cccc(c1)C=1N(CC#C)C(=O)N(c2cncc3ccccc32)C(=O)C=1n1nnc2ccccc21
SMILES	CACTVS	3.385	Clc1cccc(c1)C2=C(n3nnc4ccccc34)C(=O)N(C(=O)N2CC#C)c5cncc6ccccc56
SMILES	OpenEye OEToolkits	3.1.0.0	C#CCN1C(=C(C(=O)N(C1=O)c2cncc3c2cccc3)n4c5ccccc5nn4)c6cccc(c6)Cl
Canonical SMILES	CACTVS	3.385	Clc1cccc(c1)C2=C(n3nnc4ccccc34)C(=O)N(C(=O)N2CC#C)c5cncc6ccccc56
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	C#CCN1C(=C(C(=O)N(C1=O)c2cncc3c2cccc3)n4c5ccccc5nn4)c6cccc(c6)Cl
InChI	InChI	1.06	InChI=1S/C28H17ClN6O2/c1-2-14-33-25(18-9-7-10-20(29)15-18)26(35-23-13-6-5-12-22(23)31-32-35)27(36)34(28(33)37)24-17-30-16-19-8-3-4-11-21(19)24/h1,3-13,15-17H,14H2
InChIKey	InChI	1.06	ZAWYJTRWMXCCSD-UHFFFAOYSA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.